Kancherla Rajesh, Sharma Anju, Garg Prabha
Department of Pharmacoinformatics, National Institute of Pharmaceutical Education and Research, S. A. S. Nagar, Punjab, 160062, India.
J Imaging Inform Med. 2024 Dec 13. doi: 10.1007/s10278-024-01355-9.
The global burden of lung diseases is a pressing issue, particularly in developing nations with limited healthcare access. Accurate diagnosis of lung conditions is crucial for effective treatment, but diagnosing lung ailments using medical imaging techniques like chest radiograph images and CT scans is challenging due to the complex anatomical intricacies of the lungs. Deep learning methods, particularly convolutional neural networks (CNN), offer promising solutions for automated disease classification using imaging data. This research has the potential to significantly improve healthcare access in developing countries with limited medical resources, providing hope for better diagnosis and treatment of lung diseases. The study employed a diverse range of CNN models for training, including a baseline model and transfer learning models such as VGG16, VGG19, InceptionV3, and ResNet50. The models were trained using image datasets sourced from the NIH and COVID-19 repositories containing 8000 chest radiograph images depicting four lung conditions (lung opacity, COVID-19, pneumonia, and pneumothorax) and 2000 healthy chest radiograph images, with a ten-fold cross-validation approach. The VGG19-based model outperformed the baseline model in diagnosing lung diseases with an average accuracy of 0.995 and 0.996 on validation and external test datasets. The proposed model also outperformed published lung-disease prediction models; these findings underscore the superior performance of the VGG19 model compared to other architectures in accurately classifying and detecting lung diseases from chest radiograph images. This study highlights AI's potential, especially CNNs like VGG19, in improving diagnostic accuracy for lung disorders, promising better healthcare outcomes. The predictive model is available on GitHub at https://github.com/PGlab-NIPER/Lung_disease_classification .
肺部疾病的全球负担是一个紧迫的问题,在医疗保健机会有限的发展中国家尤为如此。准确诊断肺部疾病对于有效治疗至关重要,但由于肺部复杂的解剖结构,使用胸部X光图像和CT扫描等医学成像技术诊断肺部疾病具有挑战性。深度学习方法,特别是卷积神经网络(CNN),为使用成像数据进行疾病自动分类提供了有前景的解决方案。这项研究有可能显著改善医疗资源有限的发展中国家的医疗保健机会,为更好地诊断和治疗肺部疾病带来希望。该研究采用了多种CNN模型进行训练,包括一个基线模型和诸如VGG16、VGG19、InceptionV3和ResNet50等迁移学习模型。这些模型使用来自美国国立医学图书馆(NIH)和新冠病毒(COVID-19)数据库的图像数据集进行训练,该数据集包含8000张描绘四种肺部疾病(肺部混浊、COVID-19、肺炎和气胸)的胸部X光图像以及2000张健康胸部X光图像,采用十折交叉验证方法。基于VGG19的模型在诊断肺部疾病方面优于基线模型,在验证数据集和外部测试数据集上的平均准确率分别为0.995和0.996。所提出的模型也优于已发表的肺部疾病预测模型;这些发现强调了VGG19模型在从胸部X光图像中准确分类和检测肺部疾病方面比其他架构具有更优异的性能。这项研究突出了人工智能的潜力,特别是像VGG19这样的卷积神经网络在提高肺部疾病诊断准确性方面的潜力,有望带来更好的医疗结果。该预测模型可在GitHub上获取,网址为https://github.com/PGlab-NIPER/Lung_disease_classification 。